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A B S T R A C T
Background: Primary percutaneous coronary intervention (PCI) is the current standard of care for acute
ST elevation myocardial infarction (STEMI). Most of the data on primary PCI in acute STEMI is from
western countries. We studied the outcomes of primary PCI for acute STEMI at a tertiary care center in
North India.
Methods: Consecutive patients undergoing primary PCI for STEMI were prospectively studied during the
period from February 2103 to May 2015. The outcomes assessed were all cause in hospital mortality,
factors associated with mortality, major adverse cardiac and cerebrovascular event rate (composite of all
cause in hospital mortality, non-fatal re infarction and stroke) and procedural complications.
Results: 371 patients underwent primary PCI during the study period. The mean age was 54 years and
82.7% were males. The mean total ischemia time and door to balloon times were 6.8 h and 51 min
respectively. 96.4% patients underwent successful primary PCI. The total in hospital mortality was 12.9%.
Mortality with cardiogenic shock at presentation was 66.7% while non-shock mortality was 2.6%. In
hospital MACCE rate was 13.5%. Factors signiﬁcantly associated with mortality were KILLIP class (OR:
8.4), door to balloon time (OR 1.02), ﬁnal TIMI ﬂow (OR 0.44) and severe LV dysfunction (OR 22.0).
Procedure related adverse events were rare and there was no non-CABG associated major TIMI bleeding.
Conclusion: Primary PCI for acute STEMI is feasible in our setup and associated with high success rate,
low mortality in non-shock patients and low complication rates.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Coronary artery disease (CAD) is one of the leading causes of
mortality worldwide with increasing incidence in developing
countries like India.1 Acute STEMI is the most lethal presentation of
CAD with mortality rates in community ranging from 15 to 20%.2
Acute STEMI accounted for 60% and 37% of acute coronary
syndromes in India as per CREATE3 and Kerala ACS registries4
respectively and was associated with highest mortality among the
ACS spectrum.
Primary percutaneous coronary intervention (PCI) has been
established as the treatment of choice for patients presenting
with acute ST elevation myocardial infarction (STEMI). However* Corresponding author at: U.N. Mehta Institute of Cardiology and Research
Center, Ahmedabad 380016, India.
E-mail address: gajendra.dubey119@gmail.com (G. Dubey).
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creativecommons.org/licenses/by-nc-nd/4.0/).widespread availability and affordability of primary PCI is
still an important consideration in our country. As per the
latest data from Kerala ACS registry,4 only 19.6% of STEMI
patients underwent coronary angiography and 12.9% underwent
primary PCI.
To achieve optimal results with primary PCI it needs to be
performed in a timely manner at high volume centers by expert
operators. Whether results similar to those reported from West can
be achieved in our settings or not, is not known. So, this study was
conducted with intent to look into the outcomes of primary PCI
performed at a tertiary care center in North India.
2. Methods
2.1. Study design
This was an observational prospective study of consecutive
STEMI patients undergoing primary PCI at the All India Institute ofneous coronary intervention for acute ST elevation myocardial
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2013 to May 2015. All patients presenting with acute ST elevation
MI and undergoing primary PCI were included in the study. STEMI
Patients managed with thrombolytic therapy, or patients under-
going rescue or facilitated PCI were excluded from the study.
All the included patients were followed up till discharge from
the hospital or in hospital death and pertinent data were
prospectively collected. The study was ethically approved by the
Institute Ethics Committee.
2.2. Primary PCI procedure
Selection of patients for primary PCI was as per guideline
recommendations.5 All patients presenting within 12 h of onset of
symptoms were considered for primary PCI. Patients presenting
between 12 and 24 h of onset of symptoms were also taken up for
primary PCI if they had ongoing ischemic symptoms.
Catheterization team was activated immediately on conﬁrma-
tion of STEMI diagnosis. After loading with dual antiplatelets,
patients were immediately shifted to catheterization laboratory.
After gaining vascular access, non-culprit vessel angiogram was
done ﬁrst followed by the culprit vessel angiogram. Once the
decision to go ahead with angioplasty was taken, heparin was
administered in dosage of 70–100 U/kg to achieve an ACT of 250–
300. GPIIb/IIIa inhibitor use was left to operator’s discretion. The
choice of guidewire, balloon, stent, thrombus aspiration and IABP
was on operator’s discretion. Manual thrombus aspiration was
done with the ‘‘Thrombuster’’ thrombus aspiration catheter
(Atrium, Osaka Japan).
Only culprit vessel angioplasty was done except in cases with
cardiogenic shock where non-culprit angioplasty was also
considered. Post procedure patients were immediately shifted to
CCU. Sheaths were removed once ACT was below 180.
Hemodynamically stable patients were kept in CCU for 24–48 h
and subsequently shifted to step down unit and were discharged
on 4th or 5th day. At discharge statins in dose of 40–80 mg and
dual anti platelet (DAPT) agents were prescribed to all patients.
ACEI/ARB and beta blockers were used in all patients without
contraindications for their use.
2.3. Outcomes
The outcomes studied were all cause in hospital mortality rate,
factors associated with mortality, Major adverse cardiac and
cerebrovascular events (MACCE) and procedural complication rate.
2.4. Deﬁnitions
STEMI: It was deﬁned as symptoms of ischemia associated with
ST-segment elevation of 1 mm in limb leads and/or 2 mm in
chest leads in 2 contiguous leads, or new left bundle branch
block, or true posterior myocardial infarction with ST depression of
1 mm in 2 contiguous anterior leads.
Cardiogenic shock: Persistent hypotension with systolic blood
pressure less than 90 mmHg for at least 30 min, despite adequate
ﬂuid administration and associated with features of tissue
hypoperfusion.
Severe LV dysfunction: It was deﬁned as left ventricular
ejection fraction 30% by echocardiography.
Dyslipidemia: Fasting lipid proﬁle values were taken within
24 h of presentation with dyslipidemia deﬁned as presence of one
or more of following characteristics:
Total cholesterol 200 mg/dl, LDL cholesterol 130 mg/dl, HDL
cholesterol 40 mg/dl in males, 50 mg/dl in females and/or
triglycerides 150 mg/dl.Please cite this article in press as: Dubey G, et al. Primary percuta
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Door to balloon time: Time from arrival at the Institute to
revascularization.
Successful PCI: PCI success was deﬁned as achievement of
vessel patency with a residual stenosis of <20%.
Re-infarction: It was deﬁned as recurrence of ischemic
symptoms with new ECG changes suggestive of re-infarction.
Major bleeding: It was deﬁned as per standard TIMI criteria6
for non CABG and CABG associated bleeding.
Signiﬁcant non-infarct related artery (IRA) disease: It was
deﬁned as presence of 70% disease in epicardial vessel other than
the culprit vessel. Cut-off of 50% was used for diagnosis of
signiﬁcant left main disease.
MACCE: It was deﬁned as a composite of all cause in hospital
mortality, non-fatal reinfarction and stroke.
2.5. Statistical analysis
The data analysis was done with ‘STATA 13’ (STATA CORP,
Texas, USA). Quantitative variables are presented as mean  stan-
standard deviation. Categorical variables are presented as percen-
tages. The chi square test was used to analyze association of
categorical variables with the primary outcome. Logistic regression
analysis was used to analyze the association between quantitative
variables and the primary outcome. Multivariate logistic regression
analysis was used to study the independent association of variables
with the primary outcome.
3. Results
3.1. Study population
Overall 383 patients presented with acute STEMI during the
study period. Of these, 7 patients died in the emergency before
being shifted for primary PCI and 5 did not consent for primary PCI
and were thrombolysed. The study included the remaining
371 patients who underwent primary PCI at the institute from
February 2013 to May 2015. Baseline characteristics of these
patients are presented in Table 1. Of the 371 patients, almost 83%
were males. Mean age of the patients was 54 years with 12%
patients below 40 years of age.
Among coronary risk factors notable was high prevalence of
smoking (57%) and relatively lower prevalence of dyslipidemia
(18.6%). Importantly 37 patients (10%) had no conventional
coronary risk factors.
The mean total ischemia time and door to balloon times were
6.8 h and 51 min respectively. Anterior wall MI was the
commonest presentation and almost half of the patients were in
KILLIP class I. A relatively high percentage of patients were in
KILLIP IV at presentation.
3.2. Angiographic and procedural variables (Table 2)
Femoral was the preferred route in majority of cases. Signiﬁcant
non-infarct related artery disease was present in 50% of cases with
26% having triple vessel disease (TVD) and 24% double vessel
disease (DVD).
PCI was successful in almost 96% of cases with majority of them
receiving stents. Glycoprotein IIb/IIIa inhibitors were used in 83%
of patients, initiated in the catheterization laboratory.
Emergency CABG was done in 5 patients, indication being left
main CAD in one, triple vessel disease in one, failure to cross
guidewire in two and severe MR in one patient.neous coronary intervention for acute ST elevation myocardial
e center study from North India, Indian Heart J. (2016), http://
Table 1
Baseline characteristics. Data are number of patients (%) unless otherwise
indicated.
Total 371
Age (mean) (SD) 54.2 years (12.7 years)
Males 307 (82.75%)
Females 64 (17.25%)
Under 40 years 46 (12.3%)
Diabetes mellitus 118 (31.8%)
Dyslipidemia 69 (18.6%)
Hypertension 158 (42.6%)
Current smokers 211 (56.9%)
Family history 19 (5.1%)
Obesity 56 (15.1%)
Total ischemia time (h) (mean, SD) 6.8, 4.04
Door to balloon time (min) (mean, SD) 51.1, 29.0
Door to balloon  90 min 357 (96.2%)
Door to balloon  60 min 325 (87.6%)
Anterior MI 211 (56.9%)
Inferior MI 148 (39.9%)
Lateral 11 (2.9%)
Posterior 32 (8.6%)
RVMI 26 (7%)
KILLIP I 186 (50.1%)
KILLIP II 111 (29.9%)
KILLIP III 14 (3.8%)
KILLIP IV 60 (16.2%)
Severe LV dysfunction 150 (40.4%)
Congestive heart failure 97 (26.1%)
Complete heart block (CHB) 39 (10.5%)
Primary VT/VF 20 (5.4%)
Secondary VT/VF 8 (2.1%)
Table 3
Factors associated with mortality (multivariate analysis).
Variable Odds ratio (95% CI) p value
Door to balloon time 1.02 (1.00–1.05) 0.025
Killip class 8.47 (3.47–20.68) <0.001
Final TIMI 0.411 (0.17–0.96) 0.041
Severe LV dysfunction 22.0 (1.14–421) 0.04
Female sex 0.3 (0.05–1.67) 0.167
Age 0.99 (0.93–1.06) 0.963
Diabetes mellitus 0.98 (0.26–3.67) 0.982
Total ischemia time 1.10 (0.96–1.27) 0.156
Anterior MI 1.01 (0.16–6.36) 0.988
CHB 0.78 (0.1–5.94) 0.811
Signiﬁcant non-IRA disease 4.98 (0.77–32.02) 0.09
TVD 0.3 (0.06–1.58) 0.159
Thrombus aspiration 0.36 (0.05–2.26) 0.278
CABG 7.5 (0.03–1775.8) 0.47
CHF 0.82(0.2–3.18) 0.783
Primary VT/VF 1.93 (0.21–17.55) 0.558
Secondary VT/VF 18.24 (0.63–525.85) 0.09
Bold values indicate variables signiﬁcantly associated with mortality.
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Total all cause in hospital mortality was 12.9% (48 deaths).
Mean duration of hospital stay prior to death was 2.2 days. Of
these, almost 60% died within 24 h of admission. Mortality rates
varied signiﬁcantly within the cohort. Those in whom cardiogenicTable 2
Angiographic ﬁndings and procedural variables. Data are number of
patients (%) unless otherwise indicated.
Infarct related artery – LAD 210 (56.6%)
Infarct related artery – LCX 49 (13.2%)
Infarct related artery – RCA 105 (28.3%)
Infarct related artery – Others 7 (2.5%)
Sig Non-IRA disease 189 (50.1%)
Left main CAD 9 (2.43%)
Double vessel disease 90 (24.2%)
Triple vessel disease 97 (26.07%)
Normal coronaries/slow ﬂow 5 (1.3%)
TIMI 0 322 (86.8%)
TIMI 1 14 (3.8%)
TIMI 2 16 (4.3%)
TIMI 3 19 (5.1%)
Dual antiplatelet loading 371 (100%)
Statin loading 371 (100%)
GpIIb/IIIa 308 (83%)
PCI successful 345/358 (96.4%)
PCI unsuccessful 13/358 (3.6%)
PCI with stenting 313/345 (90.7%)
POBA 24 (6.9%)
Thrombus aspiration 143 (41.4%)
Thrombus aspiration alone 8 (2.3%)
BMS 121 (37.9%)
DES 198 (62.1%)
Number of stents (mean) 1.16
Emergency CABG 5 (1.3%)
IABP 14 (3.7%)
TPI 39 (10.5%)
Final TIMI 0 22 (5.9%)
Final TIMI 1 5 (1.3%)
Final TIMI 2 37 (9.9%)
Final TIMI 3 307 (82.7%)
Please cite this article in press as: Dubey G, et al. Primary percuta
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66.7% as compared to 2.6% in those not in cardiogenic shock.
Emergency CABG was associated with in hospital mortality of 60%.
Cardiogenic shock was the most common cause of death
accounting for 77% of deaths followed by CHF in 10% and VT/VF in
8%. One patient died from hospital acquired pneumonia with
severe sepsis and one patient died from LV free wall rupture.
Factors signiﬁcantly associated with mortality (Table 3) on
multivariate analysis were the KILLIP class, door to balloon time,
the ﬁnal TIMI ﬂow and presence of severe LV dysfunction. Those in
KILLIP class four had eight-fold higher risk of mortality as
compared to others. Increase in the door to balloon time by one
minute lead to 2% increase in mortality rates. Final TIMI 3 ﬂow was
associated with almost 60% lower mortality as compared to those
without TIMI 3 ﬂow. The risk of death was 22-fold higher in those
with severe LV dysfunction.
3.4. Complications (Table 4)
Complications related to vascular access were infrequent with
only 2.7% having local hematomas. All of them were managed
conservatively and none required transfusion or re intervention for
the same. There were no pseudoaneurysm or AV ﬁstulas.
Two patients had re-infarctions in the same territory during the
index hospital stay and were caused by subacute stent thrombosis.
Both were managed successfully with balloon angioplasty. There
was no non-CABG related TIMI major bleeding, while two patients
had CABG related major bleeding namely requiring more than
5 units of packed RBC transfusions during 48 h. The total MACCE
rate was 13.5% including 48 mortalities and two re infarctions
secondary to stent thrombosis. There were no strokes in our study
population.Table 4
Complications. Data are number of patients (%) unless otherwise indicated.
Local vascular complications 10 (2.7%)
Coronary perforation/tamponade 0
No reﬂow 9/345 (2.6%)
Re infarction 2 (0.5%)
Subacute stent thrombosis 2 (0.5%)
TIMI major bleeding (non-CABG related) 0
Stroke 0
Contrast reactions 0
Contrast induced nephropathy 4 (1.1%)
MACCE 50 (13.5%)
neous coronary intervention for acute ST elevation myocardial
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The mean duration of hospital stay prior to discharge was
approximately 5 days. Guideline directed medical therapy was
provided to all the patients at discharge. Dual antiplatelet therapy
and statins were prescribed to all the discharged patients
(323,100%). Beta blockers were prescribed to 80% patients at
discharge while Acei/ARBs were prescribed to 85% of discharged
patients.
4. Discussion
This is the ﬁrst large scale registry data on primary PCI for acute
STEMI from our Institute and North India. The 24  7 free primary
PCI program at our Institute was initiated in February 2013, and
over a period of 2 years and 3 months, almost 97% of acute STEMI
patients (371 out of 383) underwent primary PCI. In this study, we
have reported the demographic, clinical and angiographic features
and outcomes of these patients.
The mean age of patients in this study (54 years) was almost a
decade lesser than the western population.7,8 The earlier occur-
rence of acute MI in South East Asian population is well established
fact.3,9,10 The possible reasons for earlier occurrence of CAD in
South East Asian patients are multiple including genetic predispo-
sition, higher prevalence of abdominal obesity, higher Apolipo-
protein(Apo)B/ApoA1 ratio etc.
Among risk factors smoking was the most widely prevalent risk
factor, especially among the younger population (less than
40 years), often being the sole risk factor. The percentage of
current smokers in this study is higher than that seen in
American11 and European registries.12 This high prevalence of
smoking in Indians has been documented earlier also,13 with
stronger association with coronary artery disease in younger
individuals.14
Dyslipidemia was another risk factor which needs special
mention. It was seen in 18.6% of our patients which is signiﬁcantly
lower than that seen in western population.15,16 However studies
from India10,17 have consistently reported a lower prevalence of
dyslipidemia as seen in our study. The higher risk of CAD even in
absence of dyslipidemia as currently deﬁned, signiﬁes the need of
redeﬁning or modifying the cut offs for the Indian population.
Mean total ischemia time (6.9 h) in our study was signiﬁcantly
longer than that reported in studies from South India10 and
western countries.1,11 One possible reason for higher mean total
ischemia time was inclusion of patients with duration of
symptoms between 12 and 24 h with ongoing ischemia or
cardiogenic shock. Lack of awareness among patients and long
travel times also accounted for longer total ischemia time. The
Kerala ACS registry4 also reported that a diagnosis of STEMI was
associated with higher probability of symptom to door time of
more than 6 h and lack of any formal education.
The mean door to balloon time, a measure of operational
efﬁcacy of system, was 51 min in our study, well below the
recommended limit of 90 min. This is comparable to door to
balloon times achieved in studies from west8 and other centers in
our country.10 We could achieve good door to balloon times due to
coordinated efforts of the emergency medical team, a 24  7 ready
to operate catheterization laboratory and a dedicated team of
experienced interventional cardiologist.
The overall in hospital mortality seen in our trial was
signiﬁcantly higher than the 5–9% mortality reported from large
registries from western countries18,19 and from Indian studies.3,4,10
The higher mortality rate seems to be driven mainly by the high
percentage of patients with cardiogenic shock in this study.
However, the mortality rates in patients who were not in shock atPlease cite this article in press as: Dubey G, et al. Primary percuta
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mortality seen in large randomized controlled trials.20,21
As mentioned earlier, the percentage of patients with cardio-
genic shock at presentation (16%) was signiﬁcantly higher than 7–
10% incidence of shock reported in other studies on acute
myocardial infarction.22,23 Longer total ischemia time, high
percentage of anterior wall MI and inclusion of all patients in
cardiogenic shock for primary PCI irrespective of time delay as
endorsed by recent guidelines,5 seem to be responsible for this
high percentage of cardiogenic shock in our study.
The factors associated with mortality on multivariate analysis
were door to balloon time, KILLIP class, ﬁnal TIMI ﬂow and
presence of severe LV dysfunction. This data is consistent with
ﬁndings of other studies looking into predictors of mortality in
patients undergoing primary PCI.24,25
Among complications, notable feature of our study was lack of
any non-CABG related TIMI major bleeding despite extensive use
of potent DAPT, heparin and GPIIb/IIIa inhibitors. Careful
monitoring of ACT, avoidance of GP IIb/IIIa in elderly patients
and restriction of their use in patients with ACT above 300 were
key components in avoiding excessive bleeding. Also reassuring
was absence of any stroke in our study. Thrombus aspiration in a
recent large trial26 showed increased risk of stroke (0.7%) at
30 days. This was not seen in our study.
4.1. Limitations
The main limitation of this study was its observational nature.
The lack of randomization precludes assessment of impact of
therapies like GPIIb/IIIa, thrombus aspiration, IABP etc. on
mortality. Also, this was a single center study conducted at a high
volume tertiary care teaching Institute and results obtained may
not be applicable at lesser centers with lower case volumes. Finally,
there was no follow up in this study and long term outcomes
remain unknown.
5. Conclusion
Prompt primary percutaneous coronary intervention for acute
STEMI is feasible in our setup and is associated with high success
rate, low mortality rates in non-shock patients and low complica-
tion rates. The mortality associated with cardiogenic shock
continues to be high. Important predictors signiﬁcantly associated
with mortality are the door to balloon time, Killip class, ﬁnal TIMI
ﬂow and severe LV dysfunction.
Conﬂicts of interest
The authors have none to declare.
Acknowledgements
We thank all our patients and the entire cardiology department
at the All India Institute of Medical Sciences for their cooperation.
The primary PCI programme was government sponsored and no
speciﬁc grant per se was received for the study itself.
References
1. Fox KAA, Goodman SG, Klein W, et al. Management of acute coronary syndromes.
Variations in practice and outcome; ﬁndings from the Global Registry of Acute
Coronary Events (GRACE). Eur Heart J. 2002;23(August (15)):1177–1189.
2. Canto JG, Rogers WJ, Chandra NC, et al. The association of sex and payer status on
management and subsequent survival in acute myocardial infarction. Arch Intern
Med. 2002;162(March (5)):587–593.
3. Xavier D, Pais P, Devereaux PJ, et al. Treatment and outcomes of acute coronary
syndromes in India (CREATE): a prospective analysis of registry data. Lancet Lond
Engl. 2008;371(April (9622)):1435–1442.neous coronary intervention for acute ST elevation myocardial
e center study from North India, Indian Heart J. (2016), http://
G. Dubey et al. / Indian Heart Journal xxx (2016) xxx–xxx 5
G Model
IHJ-1085; No. of Pages 54. Mohanan PP, Mathew R, Harikrishnan S, et al. Presentation, management, and
outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results
from the Kerala ACS Registry. Eur Heart J. 2013;34(January (2)):121–129.
5. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the
management of ST-elevation myocardial infarction: executive summary: a report
of the American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines. Circulation. 2013;127(January (4)):529–555.
6. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding deﬁnitions for cardiovas-
cular clinical trials: a consensus report from the Bleeding Academic Research
Consortium. Circulation. 2011;123(June (23)):2736–2747.
7. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management prac-
tices, and in-hospital outcomes of patients hospitalized with acute coronary
syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol.
2002;90(August (4)):358–363.
8. Gibson CM. NRMI and current treatment patterns for ST-elevation myocardial
infarction. Am Heart J. 2004;148(November (5 suppl)):S29–S33.
9. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modiﬁable risk factors
associated with myocardial infarction in 52 countries (the INTERHEART study):
case–control study. Lancet Lond Engl. 2004;364(September (9438)):937–952.
10. Subban V, Lakshmanan A, Victor SM, et al. Outcome of primary PCI – an Indian
tertiary care center experience. Indian Heart J. 2014;66(January (1)):25–30.
11. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over
1.5 million patients with myocardial infarction in the US from 1990 through 1999:
the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol.
2000;36(December (7)):2056–2063.
12. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute
coronary syndromes: characteristics, treatment, and outcome of patients with ACS
in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27(October
(19)):2285–2293.
13. Gupta R, Gupta VP, Sarna M, et al. Prevalence of coronary heart disease and risk
factors in an urban Indian population: Jaipur Heart Watch-2. Indian Heart J.
2002;54(February (1)):59–66.
14. Sharma M, Ganguly NK. Premature coronary artery disease in Indians and its
associated risk factors. Vasc Health Risk Manag. 2005;1(3):217–225.
15. Canto JG, Kiefe CI, Rogers WJ, et al. Atherosclerotic risk factors and their association
with hospital mortality among patients with ﬁrst myocardial infarction (from thePlease cite this article in press as: Dubey G, et al. Primary percuta
infarction: Outcomes and determinants of outcomes: A tertiary car
dx.doi.org/10.1016/j.ihj.2016.11.322National Registry of Myocardial Infarction). Am J Cardiol. 2012;110(November
(9)):1256–1261.
16. Vedre A, Gurm HS, Froehlich JB, et al. Impact of prior statin therapy on arrhythmic
events in patients with acute coronary syndromes (from the Global Registry of Acute
Coronary Events [GRACE]). Am J Cardiol. 2009;104(December (12)):1613–1617.
17. Victor SM, Subban V, Alexander T, et al. A prospective, observational, multicentre
study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients
with STEMI (STEPP-AMI). Open Heart. 2014;1(1):e000133.
18. Rogers WJ, Frederick PD, Stoehr E, et al. Trends in presenting characteristics and
hospital mortality among patients with ST elevation and non-ST elevation myo-
cardial infarction in the National Registry of Myocardial Infarction from 1990 to
2006. Am Heart J. 2008;156(December (6)):1026–1034.
19. Roe MT, Messenger JC, Weintraub WS, et al. Treatments, trends, and outcomes of
acute myocardial infarction and percutaneous coronary intervention. J Am Coll
Cardiol. 2010;56(July (4)):254–263.
20. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with
thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in
Myocardial Infarction Study Group. N Engl J Med. 1993;328(March (10)):673–679.
21. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-
balloon time and door-to-balloon time with mortality in patients undergoing
angioplasty for acute myocardial infarction. JAMA. 2000;283(June (22)):
2941–2947.
22. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial
infarction. Incidence and mortality from a community-wide perspective, 1975 to
1988. N Engl J Med. 1991;325(October (16)):1117–1122.
23. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit.
A two year experience with 250 patients. Am J Cardiol. 1967;20(October (4)):
457–464.
24. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percuta-
neous coronary intervention for acute myocardial infarction: the CADILLAC risk
score. J Am Coll Cardiol. 2005;45(May (9)):1397–1405.
25. Caixeta A, Lansky AJ, Mehran R, et al. Abstract 20882: predictors of suboptimal
TIMI ﬂow after primary angioplasty for acute myocardial infarction: results from
the HORIZONS-AMI trial. Circulation. 2010;122(November (21 suppl)):A20882.
26. Jolly SS, Cairns JA, Yusuf S, et al. Randomized trial of primary PCI with or without
routine manual thrombectomy. N Engl J Med. 2015;372(April (15)):1389–1398.neous coronary intervention for acute ST elevation myocardial
e center study from North India, Indian Heart J. (2016), http://
